Additionally, chronic myeloid leukemia patients with BCR-ABL chromosomal translocation displayed alternative splicing variants of BCR-ABL when treated with imatinib, the tyrosine kinase inhibitor (40). The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.